5-132678417-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000589.4(IL4):​c.184-1297A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.347 in 152,160 control chromosomes in the GnomAD database, including 13,003 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.35 ( 13003 hom., cov: 33)

Consequence

IL4
NM_000589.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.732

Publications

47 publications found
Variant links:
Genes affected
IL4 (HGNC:6014): (interleukin 4) The protein encoded by this gene is a pleiotropic cytokine produced by activated T cells. This cytokine is a ligand for interleukin 4 receptor. The interleukin 4 receptor also binds to IL13, which may contribute to many overlapping functions of this cytokine and IL13. STAT6, a signal transducer and activator of transcription, has been shown to play a central role in mediating the immune regulatory signal of this cytokine. This gene, IL3, IL5, IL13, and CSF2 form a cytokine gene cluster on chromosome 5q, with this gene particularly close to IL13. This gene, IL13 and IL5 are found to be regulated coordinately by several long-range regulatory elements in an over 120 kilobase range on the chromosome. IL4 is considered an important cytokine for tissue repair, counterbalancing the effects of proinflammatory type 1 cytokines, however, it also promotes allergic airway inflammation. Moreover, IL-4, a type 2 cytokine, mediates and regulates a variety of human host responses such as allergic, anti-parasitic, wound healing, and acute inflammation. This cytokine has been reported to promote resolution of neutrophil-mediated acute lung injury. In an allergic response, IL-4 has an essential role in the production of allergen-specific immunoglobin (Ig) E. This pro-inflammatory cytokine has been observed to be increased in COVID-19 (Coronavirus disease 2019) patients, but is not necessarily associated with severe COVID-19 pathology. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.753 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000589.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL4
NM_000589.4
MANE Select
c.184-1297A>G
intron
N/ANP_000580.1P05112-1
IL4
NM_172348.3
c.136-1297A>G
intron
N/ANP_758858.1Q5FC01
IL4
NM_001354990.2
c.284+536A>G
intron
N/ANP_001341919.1U3LVN1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL4
ENST00000231449.7
TSL:1 MANE Select
c.184-1297A>G
intron
N/AENSP00000231449.2P05112-1
IL4
ENST00000350025.2
TSL:1
c.136-1297A>G
intron
N/AENSP00000325190.3P05112-2
IL4
ENST00000622422.1
TSL:1
c.284+536A>G
intron
N/AENSP00000480581.1U3LVN1

Frequencies

GnomAD3 genomes
AF:
0.347
AC:
52749
AN:
152042
Hom.:
12974
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.641
Gnomad AMI
AF:
0.0164
Gnomad AMR
AF:
0.347
Gnomad ASJ
AF:
0.210
Gnomad EAS
AF:
0.774
Gnomad SAS
AF:
0.195
Gnomad FIN
AF:
0.363
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.158
Gnomad OTH
AF:
0.298
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.347
AC:
52834
AN:
152160
Hom.:
13003
Cov.:
33
AF XY:
0.354
AC XY:
26321
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.641
AC:
26597
AN:
41490
American (AMR)
AF:
0.347
AC:
5304
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.210
AC:
727
AN:
3470
East Asian (EAS)
AF:
0.773
AC:
4001
AN:
5178
South Asian (SAS)
AF:
0.194
AC:
937
AN:
4826
European-Finnish (FIN)
AF:
0.363
AC:
3833
AN:
10568
Middle Eastern (MID)
AF:
0.190
AC:
56
AN:
294
European-Non Finnish (NFE)
AF:
0.158
AC:
10729
AN:
68022
Other (OTH)
AF:
0.300
AC:
635
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1426
2852
4278
5704
7130
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
460
920
1380
1840
2300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.226
Hom.:
16313
Bravo
AF:
0.367
Asia WGS
AF:
0.484
AC:
1683
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
4.6
DANN
Benign
0.52
PhyloP100
-0.73
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2243270; hg19: chr5-132014109; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.